J. Wilding

First name
Last name
Wilding, J., Bailey, C., Rigney, U., Blak, B., Beekman, W., & Emmas, C. (2016). Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study. Diabetes Ther. http://doi.org/10.1007/s13300-016-0193-8
Wilding, J., Bailey, C., Rigney, U., Blak, B., Kok, M., & Emmas, C. (2017). Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up. Prim Care Diabetes. http://doi.org/10.1016/j.pcd.2017.04.004
Wilding, J., Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., et al. (2018). Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink. BMC Med. http://doi.org/10.1186/s12916-018-1085-8